GlassScriptPhysician profile
Thomas G Habiger
NPI 1447326038
$1,716.11
in general payments reported to CMS, 2019-2025
14 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $15.69 · 2021: $205 · 2022: $176 · 2023: $424 · 2024: $389 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $429.30 | 2019-2024 | Crexont, Rytary |
| Lilly USA, LLC | $247.55 | 2024-2025 | Kisunla |
| Abbvie INC. | $236.21 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $152.33 | 2023 | Nuplazid |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2024 | Zeposia |
| Biohaven Pharmaceuticals, INC. | $124.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $114.00 | 2019 | |
| Pfizer INC. | $91.00 | 2025 | |
| Mdd US Operations, LLC | $76.82 | 2021-2022 | |
| Exact Sciences Corporation | $34.17 | 2023 | Cologuard Collection Kit |
| Celgene Corporation | $28.32 | 2024 | Zeposia |
| Almatica Pharma LLC | $24.16 | 2021 | |
| Abiomed | $16.79 | 2023 | Impella |
| Supernus Pharmaceuticals, INC. | $15.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Habiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.